首页|期刊导航|Pharmacoeconomics and Policy|Comparative review of selected health technology assessment agencies:Features and insights for health technology assessment development and improvement
Comparative review of selected health technology assessment agencies:Features and insights for health technology assessment development and improvement
Zonglin Dai Effie Ka Yue Cheung Ting Wang David Makram Bishaie Lei Si Benjamin Hon Kei Yip Yingyao Chen Ian Chi Kei Wong Andrew J.Mirelman Manuel Antonio Espinoza Xue Li
Pharmacoeconomics and Policy2026,Vol.2Issue(2):P.60-68,9.
Pharmacoeconomics and Policy2026,Vol.2Issue(2):P.60-68,9.DOI:10.1016/j.pharp.2026.06.007
Comparative review of selected health technology assessment agencies:Features and insights for health technology assessment development and improvement
摘要
关键词
Health/technology/assessment/Institutional/governance/Coverage/and/pricing/Lifecycle/management/Stakeholder/engagement分类
医药卫生引用本文复制引用
Zonglin Dai,Effie Ka Yue Cheung,Ting Wang,David Makram Bishaie,Lei Si,Benjamin Hon Kei Yip,Yingyao Chen,Ian Chi Kei Wong,Andrew J.Mirelman,Manuel Antonio Espinoza,Xue Li..Comparative review of selected health technology assessment agencies:Features and insights for health technology assessment development and improvement[J].Pharmacoeconomics and Policy,2026,2(2):P.60-68,9.基金项目
supported by the Research Impact Fund,Research Grants Council,University Grants Committee of the Hong Kong SAR,China(Project No.:R7007-22F). (Project No.:R7007-22F)